Low density lipoprotein oxidation, antioxidants, and atherosclerosis

被引:74
作者
Catapano, AL
Maggi, FM
Tragni, E
机构
[1] Univ Milan, Inst Pharmacol Sci, I-20133 Milan, Italy
[2] Univ Milan, Ctr Aterosclerosi, I-20133 Milan, Italy
关键词
D O I
10.1097/00001573-200009000-00008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Oxidized low density lipoproteins (LDLs) are believed to be the most atherogenic form of LDL. However, although a number of experimental data support this concept, the protective role of antioxidants that may prevent LDL oxidation in atherosclerosis is only partially confirmed by studies in humans. Observational and epidemiologic data as well as randomized trials failed to provide clear-cut indications because of mixed results on the protective role of antioxidants against cardiovascular diseases. In spite of the lack of a general consensus, recent data reinforce the concept that a regular intake of antioxidants present in food blocks the progression of atherosclerosis and that the reduced oxidisability of LDL may represent a good marker to follow the action of antioxidants. When it becomes possible to monitor the efficacy of any antioxidant therapy with validated markers of oxidation, the potential influence of vitamins and antioxidants on coronary artery disease will eventually be resolved. Curr Opin Cardiol 2000, 15:355-363 (C) 2000 Lippincott Williams & Wilkins, Inc.
引用
收藏
页码:355 / 363
页数:9
相关论文
共 98 条
[1]  
ACHESON RM, 1983, LANCET, V1, P1191
[2]   Baseline diene conjugation in LDL lipids as a direct measure of in vivo LDL oxidation [J].
Ahotupa, M ;
Marniemi, J ;
Lehtimäki, T ;
Talvinen, K ;
Raitakari, OT ;
Vasankari, T ;
Viikari, J ;
Luoma, J ;
Ylä-Herttuala, S .
CLINICAL BIOCHEMISTRY, 1998, 31 (04) :257-261
[3]  
Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, 1994, N Engl J Med, V330, P1029, DOI 10.1056/NEJM199404143301501
[4]   THE EFFECT OF CHOLESTEROL-LOWERING AND ANTIOXIDANT THERAPY ON ENDOTHELIUM-DEPENDENT CORONARY VASOMOTION [J].
ANDERSON, TJ ;
MEREDITH, IT ;
YEUNG, AC ;
FREI, B ;
SELWYN, AP ;
GANZ, P .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (08) :488-493
[5]  
[Anonymous], 2000, Lancet, V355, P253, DOI DOI 10.1016/S0140-6736(99)12323-7
[6]  
ARMSTRONG BK, 1975, J CHRON DIS, V36, P673
[7]   FREE-RADICAL SCAVENGING AND INHIBITION OF LIPID-PEROXIDATION BY BETA-BLOCKERS AND BY AGENTS THAT INTERFERE WITH CALCIUM-METABOLISM - A PHYSIOLOGICALLY-SIGNIFICANT PROCESS [J].
ARUOMA, OI ;
SMITH, C ;
CECCHINI, R ;
EVANS, PJ ;
HALLIWELL, B .
BIOCHEMICAL PHARMACOLOGY, 1991, 42 (04) :735-743
[8]   Atorvastatin and gemfibrozil metabolites, but not the parent drugs, are potent antioxidants against lipoprotein oxidation [J].
Aviram, M ;
Rosenblat, M ;
Bisgaier, CL ;
Newton, RS .
ATHEROSCLEROSIS, 1998, 138 (02) :271-280
[9]   Polyphenolic flavonoids inhibit macrophage-mediated oxidation of LDL and attenuate atherogenesis [J].
Aviram, M ;
Fuhrman, B .
ATHEROSCLEROSIS, 1998, 137 :S45-S50
[10]   Clinical evaluation of probucol in hypercholesterolemia: Individual lipoprotein responses and inhibitory effect on carotid atherosclerosis progression [J].
Baldassarre, D ;
Franceschini, G ;
Peruzzotti, G ;
Brusoni, B ;
Sirtori, CR .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1997, 30 (06) :784-789